According to the company, the new, 225,000-square-foot expansion is a "crucial component" of a more than $12 billion infusion ...
A federal judge ruled in favor of Merck in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent ...
Merck & Co. (MRK) on Tuesday reported fourth-quarter net income of $3.74 billion. On a per-share basis, the Rahway, New Jersey-based company said it had profit of $1.48. Earnings, adjusted for one ...
Hosted on MSN1mon
Merck eyeing 2025 launch for easier-to-use KeytrudaKeytruda, also known as pembrolizumab, accounts for the bulk of the Rahway, New Jersey-based pharmaceutical giant's revenue. However, with its U.S. patent exclusivity ending in 2028, Merck (NYSE ...
N.J., USA This news release of Merck & Co., Inc., Rahway, N.J., USA (the "company") includes "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private ...
Rahway, New Jersey-based Merck & Co., Inc. (MRK ... MRK’s underperformance is apparent compared to the iShares U.S. Pharmaceuticals ETF (IHE). The exchange-traded fund has gained about ...
RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Caroline Litchfield, executive vice president and chief financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results